Non-redundant Requirement for CXCR3 Signaling during Tumoricidal T Cell Trafficking across Tumor Vascular Checkpoints
Evans, SSNote: Order does not necessarily reflect citation order of authors.
MetadataShow full item record
CitationMikucki, M., D. Fisher, J. Matsuzaki, J. Skitzki, N. Gaulin, J. Muhitch, A. Ku, et al. 2015. “Non-redundant Requirement for CXCR3 Signaling during Tumoricidal T Cell Trafficking across Tumor Vascular Checkpoints.” Nature communications 6 (1): 7458. doi:10.1038/ncomms8458. http://dx.doi.org/10.1038/ncomms8458.
AbstractT cell trafficking at vascular sites has emerged as a key step in antitumor immunity. Chemokines are credited with guiding the multistep recruitment of CD8+ T cells across tumor vessels. However, the multiplicity of chemokines within tumors has obscured the contributions of individual chemokine receptor/chemokine pairs to this process. Moreover, recent studies have challenged whether T cells require chemokine receptor signaling at effector sites. Here, we investigate the hierarchy of chemokine receptor requirements during T cell trafficking to murine and human melanoma. These studies reveal a non-redundant role for GαI-coupled CXCR3 in stabilizing intravascular adhesion and extravasation of adoptively transferred CD8+ effectors that is indispensable for therapeutic efficacy. In contrast, functional CCR2 and CCR5 on CD8+ effectors fail to support trafficking despite the presence of intratumoral cognate chemokines. Taken together, these studies identify CXCR3-mediated trafficking at the tumor vascular interface as a critical checkpoint to effective T cell-based cancer immunotherapy.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:23993537
- HMS Scholarly Articles